Benjamin Gordon Cambridge Capital's profile

COVID-19’s Impact on Supply Chains and Syringes.

Benjamin Gordon: COVID-19’s Impact on Supply Chains and Syringes
A recent article from NBC reported that the CEO of Becton Dickinson, the world’s largest manufacturer of syringes, believes that unless people in all sectors of the production and supply chain act quickly, manufacturers may not be able to meet the increasing demand for medical supplies. As the COVID-19 situation increases in severity, this becomes an increasingly salient concern. America’s emergency personal and essential workers must keep working in order for the US to effectively flatten the curve, otherwise everyone will be put at risk if the country reopens too soon.

Benjamin Gordon, a leading expert on supply chain management, brought this news to light in a recent post on Twitter. Gordon, the CEO of Cambridge Capital, a West Palm Beach-based private equity investor in transportation, logistics, and supply chain technology businesses, is a pioneer when it comes to advocating for good supply chain management. Because the supply chain is essential in everyone’s daily lives, even those who may not realize it, it is important for those with knowledge of supply chains to bring attention to issues arising within the field.

COVID-19’s Impact on Supply Chains and Syringes.
Published:

COVID-19’s Impact on Supply Chains and Syringes.

Published:

Creative Fields